These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Gout: a curable disease that often is undertreated. Long-term treatment is proven and available, but most patients and their physicians continue to take a short-term approach. Duke Med Health News; 2014 Aug; 20(8):1-2. PubMed ID: 25230427 [No Abstract] [Full Text] [Related]
23. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study. Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879 [TBL] [Abstract][Full Text] [Related]
24. Treatment of acute gout. Schlesinger N Rheum Dis Clin North Am; 2014 May; 40(2):329-41. PubMed ID: 24703350 [TBL] [Abstract][Full Text] [Related]
26. Gout in 2006: the perfect storm. Terkeltaub R Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496 [TBL] [Abstract][Full Text] [Related]
27. [Gouty tophus]. Inani K; Mernissi F Pan Afr Med J; 2014; 17():250. PubMed ID: 25309650 [No Abstract] [Full Text] [Related]
28. Gout therapeutics: new drugs for an old disease. Burns CM; Wortmann RL Lancet; 2011 Jan; 377(9760):165-77. PubMed ID: 20719377 [TBL] [Abstract][Full Text] [Related]
29. The management of gout: it should be crystal clear. Wortmann RL J Rheumatol; 2006 Oct; 33(10):1921-2. PubMed ID: 17014007 [No Abstract] [Full Text] [Related]
30. Gout in 2010: progress and controversies in treatment. Dalbeth N Nat Rev Rheumatol; 2011 Feb; 7(2):77-8. PubMed ID: 21289611 [No Abstract] [Full Text] [Related]
31. The treatment of hyperuricaemia and gout. O'Connor JP; Emmerson BT Aust Fam Physician; 1985 Mar; 14(3):193-8. PubMed ID: 3994597 [No Abstract] [Full Text] [Related]
35. [Gout: an overview of available urate lowering therapies]. Richette P Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581 [TBL] [Abstract][Full Text] [Related]
36. [Choice between uricosurics and inhibitors of uric acid synthesis in the treatment of gout]. Kono H; Yonezawa H; Naito H Nihon Rinsho; 1975 Feb; 33(2):356-60. PubMed ID: 1170378 [No Abstract] [Full Text] [Related]
38. Treatment of gout: where are we now? Richette P Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i1-i3. PubMed ID: 29272509 [No Abstract] [Full Text] [Related]
39. Interleukin-1 as a therapeutic target in gout. Dumusc A; So A Curr Opin Rheumatol; 2015 Mar; 27(2):156-63. PubMed ID: 25633244 [TBL] [Abstract][Full Text] [Related]
40. The role of interleukin-1 and the inflammasome in gout: implications for therapy. Pope RM; Tschopp J Arthritis Rheum; 2007 Oct; 56(10):3183-8. PubMed ID: 17907163 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]